Genenta Science S.p.A. (GNTA) Key Metrics
GNTA key metrics, 2019–2025
Fiscal year ended December 31, 2025 · eurosGNTA returns How much profit the business earns on the capital it uses.
GNTA financial health Debt, liquidity and how easily interest is covered.
GNTA efficiency & capital use Working capital cycle and where the cash goes.
GNTA returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
GNTA debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
GNTA key metrics in euros
2019–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Returns & profitability | |||||||
| Return on equity (ROE) | −36.5% | −56.5% | −44.4% | −23.7% | −21.3% | −30.6% | −24.0% |
| Return on invested capital (ROIC) | −875.3% | — | −607.1% | −574.9% | −716.7% | — | — |
| Return on assets (ROA) | −26.9% | −50.1% | −41.0% | −22.5% | −20.0% | −26.8% | −21.2% |
| Return on tangible assets | −19.7% | −63.2% | −51.2% | −24.8% | −14.4% | −29.7% | −21.2% |
| Financial health | |||||||
| Total debt | €7.6M | €14,600 | €15 | — | — | — | — |
| Cash & short-term investments | €28.1M | €12.7M | €18.8M | €29.8M | €37.2M | €15.5M | €20.1M |
| Net debt | −€20.5M | −€12.6M | −€18.8M | −€29.8M | −€37.2M | −€15.5M | −€20.1M |
| Debt / equity | 0.35 | 0.00 | 0.00 | — | — | — | — |
| Debt / assets | 0.24 | 0.00 | 0.00 | — | — | — | — |
| Current ratio | 14.16 | 6.89 | 12.25 | 14.53 | 34.15 | 7.09 | 8.29 |
| Quick ratio | 14.16 | 6.89 | 12.25 | 14.46 | 34.08 | 7.07 | 8.35 |
| Interest coverage | -16.5 | — | — | -4.2 | -506.0 | -670.9 | -477.3 |
| Working capital | €27.9M | €12.4M | €19.5M | €29.5M | €37.6M | €14.2M | €18.1M |
| Invested capital | €1.3M | −€149,445 | €1.7M | €1.3M | €1.6M | −€313,934 | −€1.3M |
| Tangible asset value | €21.8M | €12.4M | €20.4M | €31.1M | €38.9M | €15.2M | €18.9M |
| Net current asset value | €19.9M | €12.1M | €19.3M | €29.4M | €37.6M | €14.2M | €18.1M |
| Capital allocation | |||||||
| Capex / depreciation | 0.27 | 0.10 | 0.32 | 4.41 | 1.84 | 10.98 | 10.98 |
| Efficiency | |||||||
| Days of inventory on hand | — | — | 633.2 | 6,724.9 | 3,721.9 | -14,019.9 | — |
| Days payables outstanding | 12,362.2 | 2,404.7 | 6,515.9 | 42,121.9 | 26,676.0 | 116,380.4 | — |
| Receivables turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables turnover | 0.03 | 0.15 | 0.06 | 0.01 | 0.01 | 0.00 | — |
| Inventory turnover | — | — | 0.58 | 0.05 | 0.10 | — | — |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average receivables | €1.4M | €1.7M | €1.8M | €1.5M | €1.1M | €595,110 | €429,589 |
| Average payables | €913,548 | €306,402 | €744,508 | €691,954 | €372,440 | €563,728 | €572,440 |
| Average inventory | — | — | €72,346 | €110,472 | €51,964 | −€67,910 | −€163,491 |
| Intangibles / total assets | 0.0% | 0.6% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from GNTA's annual financial statements (latest annual report filed April 1, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in euros; data from EODHD. Averages use the opening and closing balance of each year.
GNTA valuation and financial ratios
Genenta Science S.p.A. earned a return on equity of −36.5% and a return on invested capital of −875.3% in fiscal 2025. It ended the year with €7.6 million of debt and €28.1 million in cash and short-term investments, a net cash position of €20.5 million.
See the GNTA income statement, the GNTA chart for price history, or the GNTA stock overview for the latest quote and news.
GNTA key metrics FAQ
What is Genenta Science S.p.A.'s return on equity?
Genenta Science S.p.A.'s return on equity (ROE) was −36.5% in fiscal 2025: net income of -€6.3 million on average shareholders' equity of €17.2 million.
What is Genenta Science S.p.A.'s ROIC?
Genenta Science S.p.A.'s return on invested capital was −875.3% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Genenta Science S.p.A. have?
Genenta Science S.p.A. had total debt of €7.6 million at the end of fiscal 2025, a debt-to-equity ratio of 0.35 and more cash than debt.
What is Genenta Science S.p.A.'s current ratio?
Genenta Science S.p.A.'s current ratio was 14.16 at the end of fiscal 2025: current assets were 14.16 times current liabilities.